Auteurs

Quilichini PP - Chiron C - Ben-Ari Y - Gozlan H

Journal

Epilepsia

Abstract

Stiripentol (STP) is currently an efficient drug for add-on therapy in infantile epilepsies because it improves the efficacy of antiepileptic drugs (AEDs) through its potent inhibition of liver cytochromes P450. In addition, STP directly reduces seizures in several animal models of epilepsy, suggesting that it might also have anticonvulsive effects of its own. However, its underlying mechanisms of action are unknown.

Lien Pubmed

Lire l'article